Grant: Undergraduate: Mobility, musculoskeletal health and arthritis - ICS
University of Toronto
$4,950.00
Biomaterial stiffness regulation of mesenchymal stem cell osteogenic differentiation
EF 2009-10
Résumé
Musculoskeletal disorders are among the most important health care challenges in Canada and other developed nations. We are designing biomaterials that direct stem cells to regenerate musculoskeletal tissues, such as bone. We and others have found that biomaterials that are too soft or too hard discourage bone formation by stem cells, suggesting there is an optimum biomaterial stiffness for bone regeneration. However, the molecular signals involved in stiffness regulation of bone formation are unknown. In the proposed project, we will test if a molecule called FHL2 plays a role in stiffness regulation of bone formation from stem cells. This work will provide important insights into stem cell bioengineering and biomaterial design that ultimately will translate to clinically-relevant functional engineered skeletal tissues, which have not been fully realized to date.
Programme
Undergraduate: Mobility, musculoskeletal health and arthritis - ICS
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
205384
Name
Chen Chien-Shun
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Musculoskeletal Health and Arthritis
Theme2
Biomedical
Prcname2
Undergraduate: Mobility, musculoskeletal health & arthritis - IMHA
Projecttitle
Biomaterial stiffness regulation of mesenchymal stem cell osteogenic differentiation
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$4,950
Cihrequipment2
$0
Programname2
Undergraduate: Mobility, musculoskeletal health and arthritis - ICS
Keyworddelim
Biomaterials; Biomechanics; Bone; Fhl2; Mesenchymal Stem Cells; Osteogenesis; Tissue Engineering
Abstract
Musculoskeletal disorders are among the most important health care challenges in Canada and other developed nations. We are designing biomaterials that direct stem cells to regenerate musculoskeletal tissues, such as bone. We and others have found that biomaterials that are too soft or too hard discourage bone formation by stem cells, suggesting there is an optimum biomaterial stiffness for bone regeneration. However, the molecular signals involved in stiffness regulation of bone formation are unknown. In the proposed project, we will test if a molecule called FHL2 plays a role in stiffness regulation of bone formation from stem cells. This work will provide important insights into stem cell bioengineering and biomaterial design that ultimately will translate to clinically-relevant functional engineered skeletal tissues, which have not been fully realized to date.
Competitiondate
201003
Approvedterm2
0 yr 3 mths
Pinamesdelim
Chen, Chien-Shun
Approvedterm
0 an 3 mois
Cihrcontribution2
~ $4,950~ $0~